PRESS RELEASE ABBVIE’S NEW ORAL THERAPY VENCLEXTA™ NOW AVAILABLE FOR CANADIANS WITH A DIFFICULT-TO-TREAT BLOOD CANCER   

First Page		Document Content
Date: 2018-07-18 10:51:03		PRESS RELEASE ABBVIE’S NEW ORAL THERAPY VENCLEXTA™ NOW AVAILABLE FOR CANADIANS WITH A DIFFICULT-TO-TREAT BLOOD CANCER    Add to Reading List Source URL: www.abbvie.ca Download Document from Source Website File Size: 328,05 KB Share Document on Facebook